Frequently Asked Questions

The most common type of heart defect is a ventricular septal defect (VSD).

Uterine fibroid embolization is a very effective procedure with an approximate success rate of 85%. Most individuals who undergo the procedure have a dramatic improvement in their symptoms and a decrease in size of their uterine fibroids.

Patients should discuss their ability to proceed with UFE with their provider. Patients with an active pelvic infection, certain uncorrectable bleeding problems, endometrial cancer, extremely large fibroids, or a desire for fertility preservation are poor candidates for this procedure.

Uterine Artery Embolization: A Safe and Effective, Minimally Invasive, Uterine-Sparing Treatment Option for Symptomatic Fibroids.

Conclusions. TURP could achieve improved Qmax and QoL compared to PAE. Therefore, for patients with BPH and lower urinary tract symptoms (LUTS), TURP was superior to PAE.

Prostate artery embolization (PAE) is a minimally invasive treatment for enlarged prostate. It is an outpatient procedure and requires less recovery time than surgery to treat enlarged prostate. PAE also has a lower risk of side effects than other surgical treatments, including urinary incontinence and lower sex drive.

Prostate artery embolisation is a minimally invasive, non-surgical new treatment option for prostate enlargement. PAE blocks off the blood flow to the small arteries supplying the prostate gland making the gland shrink and allowing a better flow of urine.

Prostate artery embolization (PAE) is a minimally invasive procedure performed by an interventional radiologist on an outpatient basis that involves targeted release of microscopic particles into the arteries that feed the prostate gland

A. Individual patient outcomes depend on several factors, including age, proper patient selection, target selection and accuracy of final electrode location, programming settings, adjustments in medicines following DBS. B. Symptoms of PD that improve with levodopa, improve after DBS. The only exception is tremor which will subside after DBS, even if it is not relieved by levodopa. C. Partial or incomplete response to DBS in PD patients may be partly due to incorrect patient selection (patients not having PD but other diseases resembling PD) or suboptimal DBS electrode placement. D. Unrealistic expectations from DBS can also result in patients being dissatisfied with the treatment. E. A critical factor influencing successful outcomes for DBS is a multidisciplinary team that specializes in the care of patients with DBS devices. The typical team includes a movement disorder specialist, a neurosurgeon who has a specialty training in stereotactic and functional neurosurgery and a neuropsychologist who has knowledge and experience assessing cognitive, mood and behavioural changes in PD. Patient outcomes are better when DBS surgeries are performed regularly by the team in high volume centres. F. Device programming and management of medications following DBS should ideally be provided by an experienced movement disorder specialist.

The different abnormal movements are shaking (tremor), stiffness of muscles, slowness and loss of balance (together called parkinsonism), twisted postures (dystonia) abrupt jerks (myoclonus), dance-like flowing movements (chorea) and stereotyped rapid jerks and involuntary sounds (tics). Many diseases that produce movement disorders result from degeneration of brain cells in areas controlling movement and do not have an obvious cause or may be due to a genetic change. These movements can develop as a consequence of injury, infections, inflammation, metabolic disturbances and tumours of the brain or as side effects of certain drugs. Neurologists who are specialists in movement disorders offer diagnosis and treatment for such conditions through dedicated movement disorder clinics.